Thu, April 11, 2013
[ Thu, Apr 11th 2013 ] - Market Wire
15 PM EDT
Wed, April 10, 2013
Tue, April 9, 2013
[ Tue, Apr 09th 2013 ] - Market Wire
30 a.m. ET
Mon, April 8, 2013
Sat, April 6, 2013
Fri, April 5, 2013
Thu, April 4, 2013
Wed, April 3, 2013
Tue, April 2, 2013
Mon, April 1, 2013
Fri, March 29, 2013
Thu, March 28, 2013
Wed, March 27, 2013
Tue, March 26, 2013
Mon, March 25, 2013
[ Mon, Mar 25th 2013 ] - Market Wire
Health Canada Decision Appealed
Sun, March 24, 2013
Fri, March 22, 2013
Thu, March 21, 2013
Wed, March 20, 2013
[ Wed, Mar 20th 2013 ] - Market Wire
00am ET
Tue, March 19, 2013
Mon, March 18, 2013
Sun, March 17, 2013
Fri, March 15, 2013
Thu, March 14, 2013

SpectraScience Schedules Business Update Conference Call


//health-fitness.news-articles.net/content/2013/ .. e-schedules-business-update-conference-call.html
Published in Health and Fitness on by Market Wire   Print publication without navigation


March 28, 2013 17:00 ET

SpectraScience Schedules Business Update Conference Call

SAN DIEGO, CA--(Marketwire - Mar 28, 2013) - SpectraScience, Inc. (OTCQB: [ SCIE ]) today announced that the Company will hold a conference call at 4:30 p.m. Eastern (1:30 p.m. Pacific) on April 5th to provide an update on its business.

To access the call, please dial 877-293-5456 and provide the Conference ID: 30821575. The conference call will also be broadcast live via the Internet and can be accessed via link through the "Investor Relations" page of the Company's website, [ www.spectrascience.com ].

At the conclusion of the call, a replay will be available until April 11th 2013. To access the replay of the call dial (855) 859-2056 and provide the same Conference ID. A webcast archive will be available at [ www.spectrascience.com ] shortly after the call as well.

About SpectraScience, Inc.

SpectraScience is a San Diego based medical device company that designs, develops, manufactures and markets light-based analysis systems capable of determining whether tissue is normal, pre-cancerous or cancerous without physically removing tissue from the body. The WavSTAT Optical Biopsy System uses light to optically diagnose tissue and provide the physician with an immediate analysis. With approval for sale under the CE Mark for the European Union, the WavSTAT System is the first commercially available product that incorporates this innovative technology for clinical use.



Publication Contributing Sources